PDCD1 and head and neck squamous cell carcinoma: The blockade of the programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) axis by means of ICI is considered a landmark event in several malignancies, including SCCHN, resulting in clear survival benefit for patients [2,3,4,5].